7:46 AM ET
8-K
Clinical Trial Data
Valion Bio Clinical Trial Data
Valion Bio announced positive final safety data from a NIAID-funded study of its lead biologic candidate, Entolimod, conducted by the Armed Forces Radiobiology Research Institute (AFRRI). The study found no evidence of treatment-related toxicity or hematologic disruption in mice, supporting the advancement to a fully funded therapeutic study evaluating survival and gastrointestinal recovery following radiation exposure.
- Counterparty
- Armed Forces Radiobiology Research Institute
- Term
- 14-day observation period